Meeting
2017 ASCO Annual Meeting
Association of delayed adjuvant therapy and overall survival in early stage endometrial cancer.
Authors
Leo Luo
Memorial Sloan Kettering Cancer Center, New York, NY
Leo Luo , Weiji Shi , Zhigang Zhang , C. Jillian Tsai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 5590)
DOI
10.1200/JCO.2017.35.15_suppl.5590
Abstract #
5590
Poster Bd #
412
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
CCTG EN10: A phase II study of tailored adjuvant therapy in POLE-mutated and p53-wildtype/NSMP early-stage endometrial cancer (EC)—RAINBO BLUE and TAPER.
First Author: Jessica N. McAlpine
Poster
2019 Genitourinary Cancers Symposium
Does increasing time to surgery affect survival in stage I renal cell carcinoma? Analysis of the national cancer database.
First Author: Brittney Cotta
Poster
2018 ASCO Annual Meeting
STATEC: A randomised trial of non-selective versus selective adjuvant therapy in high risk apparent stage 1 endometrial cancer.
First Author: Tim Mould
Poster
2018 ASCO Annual Meeting
Preoperative olaparib in early-stage endometrial cancer (EC): A phase 0, window of opportunity trial to evaluate the PARP inhibition effect, targeting cell cycle-related proteins (POLEN study).
First Author: Ignacio Romero